Nelson Advisors featured in The Daily Brief's 'Sopris Buys Blackford From Bayer, Silent on Its 45 AI Vendors' article

Nelson Advisors featured in The Daily Brief's 'Sopris Buys Blackford From Bayer, Silent on Its 45 AI Vendors' article.

Sopris Capital has closed its purchase of Blackford Analysis from Bayer, reported October 9th, and is merging it into Azra AI. The only public commitment covers existing customers, with nothing on pricing, BAAs or the 45 plus AI vendors on the platform.

Source: https://www.beri.net/article/sopris-blackford-analysis-acquisition-bayer-azra-ai-radiology-ai-orchestration-customer-continuity

Why Azra AI Wants an Imaging Platform

Azra wants Blackford's detections feeding its follow-up queues. Azra, based in Nashville, describes itself as an overlay on the EHR with bidirectional integration, where the EHR stays the system of record and Azra acts as the patient management layer. It sells incidental findings management, oncology navigation, clinical trial matching and cancer registry automation, and claims deployment at more than 1,500 sites. It names no customers.

The two companies were already partners. Their August 5, 2026 announcement paired Blackford's 130-plus imaging apps with Azra's navigation tools. Azra CEO John Marshall said, "A finding that is detected but not followed up on is not a win for the patient." A Nelson Advisors write-up of the deal describes the acquisition as formalising that commercial relationship, says Blackford managing director James Holroyd will continue to lead imaging operations, and says existing commercial distribution agreements "remain fully operational." That piece is an adviser's commentary, not a Sopris filing.

https://www.healthcare.digital/single-post/nelson-advisors-capitalising-on-healthcare-ai-infrastructure-sopris-capital-s-acquisition-of-blac